Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 5Phase NA 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2Phase 1/2 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 7Weight Gain 1Prostatic Neoplasms 1Pathologic Complete Response 1Obesity 1Endometrial Adenocarcinoma 1Diabetes, Gestational 1Diabetes Mellitus 1Breast Neoplasms 1

Interventions

Capecitabine 16Paclitaxel 12Docetaxel 10Cyclophosphamide 10Epirubicin 8Gemcitabine 7Letrozole 6Doxorubicin 6Carboplatin 6Trastuzumab 5Vinorelbine 4Cisplatin 4pertuzumab 3exemestane 3Neoadjuvant Therapy 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3130-nm albumin-bound paclitaxel 3apatinib 2Zoledronic Acid 2Thiotepa 2Taxes 2Tamoxifen 2Standard of Care 2Radiosurgery 2Melatonin 2Lapatinib 2Injections 2Goserelin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Neoplasms × Metformin × Clear all
NCT04387630 2020-06-11

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Mansoura University

Phase 2/3 Unknown
120 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡